Georges Imbert
Novartis (Switzerland)(CH)
Publications by Year
Research Areas
Genetic Neurodegenerative Diseases, Mitochondrial Function and Pathology, Alzheimer's disease research and treatments, Neurological disorders and treatments, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats(1996)851 cited
- → Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion(1997)770 cited
- → Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias(1995)653 cited
- → Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form(1995)446 cited
- → Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study(2012)301 cited
- → Origin of the expansion mutation in myotonic dystrophy(1993)212 cited
- → Controlled Protein Precipitation in Combination with Chip-Based Nanospray Infusion Mass Spectrometry. An Approach for Metabolomics Profiling of Plasma(2005)92 cited
- → Male with typical fragile X phenotype is deleted for part of the FMR1 gene and for about 100 kb of upstream region(1994)57 cited
- → Differential distribution of the normal and mutated forms of huntingtin in the human brain(1997)54 cited
- → The human small conductance calcium-regulated potassium channel gene ( hSKCa3 ) contains two CAG repeats in exon 1, is on chromosome 1q21.3, and shows a possible association with schizophrenia(1998)41 cited